Flash Focus: Indonesia Banks - MSCI Standalone Proposal: Pakistan 2008 Shows the Risk, and the Way Back

On 15-Oct-26, MSCI launched a consultation on reclassifying Indonesia from Emerging to Standalone Market status, skipping Frontier altogether, citing limited ownership transparency, continued suspected coordinated trading and no evidence of meaningful enforcement. Downgrade is now the default unless the consultation finds clear evidence of material improvement, with feedback open until 30-Apr-27 and a final decision by 30-Jun-27. OJK's same-day response reiterated its commitment to reform but offered no new measures.

The big-4 banks will carry most of the flow, even though the problem lies elsewhere. BBCA, BBRI, BMRI and BBNI now make up 71.7% of the MSCI Indonesia Index, which has been cut to just nine constituents and USD53.4bn of free float market cap, with BBCA alone at 31.4%. With no capital controls, we expect deletion at market prices rather than at effectively zero as in Nigeria and Russia, so passive selling would go through the market. BRIS, which is not in the index, is insulated from this direct pressure.

Pakistan 2008 is the only true precedent, as the only market MSCI removed from EM because of its own market authority's actions rather than a currency or access problem. After the Karachi floor rule froze trading, bank forward P/B fell 39-51% relative to MSCI EM before the floor and a further 40-46% after MSCI's 10-Dec-08 announcement, before recovering 11-27% within a year. Indonesia has already de-rated c.19% relative to EM on forward P/B since the 27-Jan-26 freeze and trades at 8.5x forward P/E and 1.38x forward P/B, 2.7 and 2.1 standard deviations below its 20-year averages. With stocks still freely tradeable, a gradual flow-driven grind looks more likely than a Pakistan-style collapse.

We remain selective on Indonesian banks. We remain positive on BBCA, which carries the largest passive overhang but would be the first stock foreign investors return to, and we would accumulate on flow-driven weakness. BRIS remains our other top pick given its limited foreign float and absence from the MSCI Indonesia Index. We remain cautious on BMRI amid tight liquidity and constrained capital. The key catalyst is visible enforcement, not price support: announced manipulation cases with sanctions and a binding, dated minimum free float rule before the 30-Apr-27 feedback deadline.